Ology Bioservices has secured a pair of contracts worth $135.4M combined from the Department of Defense to develop a medical
TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and
GovCon WireYour Direct Source for Government Contracting News
